Trial site
Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital
- 6running trials
- 10closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Heart failure3 trials
- Atrial fibrillation2 trials
- Diffuse large B-cell lymphoma2 trials
- Multiple myeloma2 trials
- Acute myeloid leukaemia1 trial
- Coronary artery disease1 trial
- Follicular lymphoma1 trial
- High blood pressure1 trial
- Hodgkin lymphoma1 trial
- IgA nephropathy1 trial
- Mantle cell lymphoma1 trial
- Prostate cancer1 trial
- and 1 more
- Phase
- Phase 38 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 11 trial
- Phase 41 trial
- Status
- Completed7 trials
- Active, not recruiting3 trials
- Recruiting2 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Regeneron Pharmaceuticals5 trials
- Eli Lilly and Company2 trials
- Takeda2 trials
- Boston Scientific Corporation1 trial
- Gilead Sciences1 trial
- and 5 more
Running trials
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Active, not recruiting
A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation1 recruiting
- Heart failure1 recruiting
- IgA nephropathy1 recruiting
- Stroke1 recruiting
Closed trials
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Recruiting
Terminated
Completed
Completed
POLARx™ Cardiac Cryoablation System Post Market Clinical Study (POLAR SMART)
Completed
Terminated
Completed
A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure
Completed
Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Site data: ClinicalTrials.govUpdated 19 Nov 2026